Traws Pharma, Inc. (TRAW)
$0.42-6.67%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4M
- Beta
- 1.53
- P/E (TTM)
- -1.04
- Short % float
- 11.59%
- Days to cover
- 1.0
- SI change
- +12.8%
- 1W
- -22.22%
- 1M
- -25.00%
- vs SPY 1W
- -22.64%
- vs SPY 1M
- -27.06%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on TRAW?
- LOPJLB’s latest quantitative signal on Traws Pharma, Inc. (TRAW) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TRAW in?
- Traws Pharma, Inc. (TRAW) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Traws Pharma, Inc. (TRAW) do?
- Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections and various forms of cancer. Its pipeline includes experimental treatments specifically designed to overcome drug resistance in influenza and COVID-19. These promising candidates include TRX01 (trav…